Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Tarsus Pharmaceuticals (TARS) Return on Assets (2020 - 2025)

Historic Return on Assets for Tarsus Pharmaceuticals (TARS) over the last 6 years, with Q3 2025 value amounting to 0.16%.

  • Tarsus Pharmaceuticals' Return on Assets rose 2000.0% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year increase of 2000.0%. This contributed to the annual value of 0.36% for FY2024, which is 1900.0% up from last year.
  • Latest data reveals that Tarsus Pharmaceuticals reported Return on Assets of 0.16% as of Q3 2025, which was up 2000.0% from 0.18% recorded in Q2 2025.
  • Over the past 5 years, Tarsus Pharmaceuticals' Return on Assets peaked at 0.02% during Q2 2021, and registered a low of 0.51% during Q4 2023.
  • Its 5-year average for Return on Assets is 0.27%, with a median of 0.25% in 2022.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -2500bps in 2023, then skyrocketed by 2500bps in 2025.
  • Over the past 5 years, Tarsus Pharmaceuticals' Return on Assets (Quarter) stood at 0.07% in 2021, then crashed by -301bps to 0.26% in 2022, then plummeted by -93bps to 0.51% in 2023, then skyrocketed by 41bps to 0.3% in 2024, then soared by 48bps to 0.16% in 2025.
  • Its Return on Assets was 0.16% in Q3 2025, compared to 0.18% in Q2 2025 and 0.23% in Q1 2025.